HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Can we use mineralocorticoid receptor blockade in diabetic patients with resistant hypertension? Yes we can! But it may be a double-edged sword.

AuthorsMichel Azizi, Matthieu Monge, Aurélien Lorthioir, Guillaume Bobrie, Laurence Amar
JournalJournal of hypertension (J Hypertens) Vol. 31 Issue 10 Pg. 1948-51 (Oct 2013) ISSN: 1473-5598 [Electronic] England
PMID24107727 (Publication Type: Editorial, Comment)
Chemical References
  • Spironolactone
Topics
  • Blood Pressure (drug effects)
  • Diabetes Complications (drug therapy)
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Spironolactone (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: